Thompson, Matthew A.
Martin, Stephen A.
Hislop, Brady D.
Younkin, Roubie
Andrews, Tara M.
Miller, Kaleena
June, Ronald K.
Adams, Erik S.
Funding for this research was provided by:
National Institute of General Medical Sciences (5P20GM104417-07, 5P20GM104417-07, 5P20GM104417-07, 5P20GM104417-07, P20GM103474, 5P20GM104417-07)
Directorate for Engineering (1554708 and 2140127)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (5R01AR073964)
Article History
Received: 15 June 2022
Accepted: 11 November 2022
First Online: 31 January 2023
Declarations
:
: This study was approved by the Montana State University Institutional Review Board (EA043019) whose guidelines conform to the Common Rule (US 45 CFR 46). All participants provided informed consent on an IRB-approved consent form.
: NA.
: Dr. June owns stock in Beartooth Biotech which was not involved in this study. All other authors have no declared conflicts.